Skip to main content

Ramon Martí Seves

Institutions of which they are part

Head of group
Neuromuscular and Mitochondrial Pathology
Vall Hebron Institut de Recerca

Ramon Martí Seves

Institutions of which they are part

Head of group
Neuromuscular and Mitochondrial Pathology
Vall Hebron Institut de Recerca

Projects

Desenvolupament i validació d'un mètode per a la determinació simultània dels citostàtics més prescrits en un hospital de tercer nivell

IP: -
Collaborators: Elena García Arumí, Ramon Martí Seves, Maria Josep Carreras Soler
Funding agency: Col·legi de Farmacèutics de Barcelona
Funding: 9000
Reference: COFB-2012-01
Duration: 18/06/2012 - 17/06/2013

Estudio preclínico del tratamiento del MNGIE mediante terapia génica, usando un vector lentivírico en un modelo murino. Seguimiento a largo plazo y bajo sobrecarga de timdina.

IP: Ramon Martí Seves
Collaborators: Raquel Cabrera Perez, Miriam Izquierdo Sans
Funding agency: CIBER Enfermedades Raras
Funding: 12400
Reference: PCIBERER-2012-01
Duration: 01/09/2012 - 31/08/2013

European registry of patients with McArdle disease and very rare muscle glycogenolytic disorders (MGD) with exercise intolerance as tha major symptom (PR-MDMGD) Contract 20121214

IP: Ramon Martí Seves
Collaborators: -
Funding agency: Ex. Agency for Health Consumers (EAHC)-CHAFEA
Funding: 365773
Reference: EUROMAC_EAHC2011
Duration: 23/03/2013 - 22/12/2016

Factores determinates de la expresión fenotípica de la enfermedad de McArdle: optimización del algoritmo diagnóstico de pacientes y caracterización de un modelo murino knock-in

IP: Ramon Martí Seves
Collaborators: Miriam Izquierdo Sans
Funding agency: Instituto de Salud Carlos III
Funding: 54000
Reference: FI11/00709
Duration: 01/09/2011 - 31/08/2015

Related news

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.

The newly developed analytical workflow could in the future be introduced as a comprehensive diagnostic test for patients with mitochondrial diseases.

Related professionals

Mariona Morell Daniel

Mariona Morell Daniel

Predoctoral researcher
Childhood Cancer and Blood Disorders
Read more
Monica Carreras Burrull

Monica Carreras Burrull

Clinical Research Development Directorate
Read more
Mariel Rojas Lora

Mariel Rojas Lora

Predoctoral researcher
Shock, Organ Dysfunction and Resuscitation
Read more
Garcia Blanco, Alejandra

Garcia Blanco, Alejandra

Research technician
Neurodegenerative Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.